Dr Reddy’s Lab launches carmustine in the US market
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
The interim analysis showed that the MVC-COV1901 vaccine has a good safety profile and elicits promising neutralising antibody titres
The consortium envisages carrying out surveillance of important bacterial, viral and parasitic infections of zoonotic as well as transboundary pathogens
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
It has planned an investment of over Rs 80 crore in the next five years
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
In collaboration with RAND Europe, the Vitality calculator predicts an individual's healthspan and future health risks
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
Harvard Medical School will deliver the first customized program, ‘Accelerate’, to create the next generation of leading experts in clinical development and medical affairs
Subscribe To Our Newsletter & Stay Updated